(Q51180371)

English

Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Helicobacter pylori

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Mika Watanabe

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Jun Kato

2

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Izumi Inoue

3

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Noriko Yoshimura

4

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Takeichi Yoshida

5

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Chizu Mukoubayashi

6

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Hisanobu Deguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Shotaro Enomoto

8

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Kazuki Ueda

9

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Takao Maekita

10

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Mikitaka Iguchi

11

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Hideyuki Tamai

12

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Hirotoshi Utsunomiya

13

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Nobutake Yamamichi

14

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Mitsuhiro Fujishiro

15

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Masataka Iwane

16

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Tatsuya Tekeshita

17

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Osamu Mohara

18

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Toshikazu Ushijima

19

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Masao Ichinose

20

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

language of work or name

0 references

publication date

28 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

131

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

11

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

2632-2642

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

Carcinogenesis of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Review article: helicobacter pylori and molecular events in precancerous gastric lesions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Fundal atrophic gastritis as a risk factor for gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Pathology and molecular biology of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Helicobacter pylori infection and chronic gastritis in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradication

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Hyperrugosity in gastric carcinoma: radiographic, endoscopic, and pathologic features

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Focus on gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Helicobacter pylori typing as a tool for tracking human migration

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27514

21 January 2018

Identifiers

10.1002/IJC.27514

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/22383377

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51180371&oldid=1237367707"